Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1986 Jun;52(3):853–857. doi: 10.1128/iai.52.3.853-857.1986

Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.

M C Cerquetti, D O Sordelli, J A Bellanti, A M Hooke
PMCID: PMC260938  PMID: 3086235

Abstract

Lung defenses against Pseudomonas aeruginosa were investigated in C5-deficient strains of mice with different genetic backgrounds. We studied pulmonary clearance and cell responses after aerosol exposure to P. aeruginosa in C5-deficient B10.D2/oSnJ and DBA/2J mice and their closest C5-sufficient counterparts, B10.D2/nSnJ and DBA/1J mice. Different patterns of lung clearance and pulmonary cell responses were found for the two C5-deficient strains. C5-deficient B10.D2/oSnJ mice showed defective lung clearance of P. aeruginosa 4 h after challenge compared with C5-sufficient B10.D2/nSnJ animals. This finding was associated with a decreased number of polymorphonuclear leukocytes recruited into the airways during the same time. Interestingly, C5-deficient DBA/2J mice recruited higher numbers of polymorphonuclear leukocytes than did C5-sufficient DBA/1J mice by 4 h after aerosolization. Nevertheless, lung clearance of P. aeruginosa in DBA/2J mice was not as effective as in C5-sufficient DBA/1J mice, suggesting that other functions of C5 besides chemotaxism could be involved. Lung clearance of P. aeruginosa was also investigated in C5-deficient and -sufficient hybrids sharing the same genetic background (DBA/2J X B10.D2). The results suggested that murine lung clearance of P. aeruginosa is markedly affected by lack of C5 in a specific genetic background (B10.D2).

Full text

PDF
853

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V. Complement deficiency states. Medicine (Baltimore) 1978 Jan;57(1):1–23. doi: 10.1097/00005792-197801000-00001. [DOI] [PubMed] [Google Scholar]
  2. Baggiolini M., Dewald B. The neutrophil. Int Arch Allergy Appl Immunol. 1985;76 (Suppl 1):13–20. doi: 10.1159/000233730. [DOI] [PubMed] [Google Scholar]
  3. Cerquetti M. C., Sordelli D. O., Ortegon R. A., Bellanti J. A. Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect Immun. 1983 Sep;41(3):1071–1076. doi: 10.1128/iai.41.3.1071-1076.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chenoweth D. E., Goodman M. G. The C5a receptor of neutrophils and macrophages. Agents Actions Suppl. 1983;12:252–273. doi: 10.1007/978-3-0348-9352-7_15. [DOI] [PubMed] [Google Scholar]
  5. Chenoweth D. E., Goodman M. G., Weigle W. O. Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages. J Exp Med. 1982 Jul 1;156(1):68–78. doi: 10.1084/jem.156.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Egwang T. G., Befus A. D. The role of complement in the induction and regulation of immune responses. Immunology. 1984 Feb;51(2):207–224. [PMC free article] [PubMed] [Google Scholar]
  7. Goodman M. G., Chenoweth D. E., Weigle W. O. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J Exp Med. 1982 Sep 1;156(3):912–917. doi: 10.1084/jem.156.3.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gross G. N., Rehm S. R., Pierce A. K. The effect of complement depletion on lung clearance of bacteria. J Clin Invest. 1978 Aug;62(2):373–378. doi: 10.1172/JCI109138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Heidbrink P. J., Toews G. B., Gross G. N., Pierce A. K. Mechanisms of complement-mediated clearance of bacteria from the murine lung. Am Rev Respir Dis. 1982 May;125(5):517–520. doi: 10.1164/arrd.1982.125.5.517. [DOI] [PubMed] [Google Scholar]
  10. Hugli T. E., Müller-Eberhard H. J. Anaphylatoxins: C3a and C5a. Adv Immunol. 1978;26:1–53. doi: 10.1016/s0065-2776(08)60228-x. [DOI] [PubMed] [Google Scholar]
  11. Hunninghake G. W., Gallin J. I., Fauci A. S. Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. Am Rev Respir Dis. 1978 Jan;117(1):15–23. doi: 10.1164/arrd.1978.117.1.15. [DOI] [PubMed] [Google Scholar]
  12. Larsen G. L., Mitchell B. C., Harper T. B., Henson P. M. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am Rev Respir Dis. 1982 Aug;126(2):306–311. doi: 10.1164/arrd.1982.126.2.306. [DOI] [PubMed] [Google Scholar]
  13. Nilsson U. R., Müller-Eberhard H. J. Deficiency of the fifth component of complement in mice with an inherited complement defect. J Exp Med. 1967 Jan 1;125(1):1–16. doi: 10.1084/jem.125.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Onofrio J. M., Toews G. B., Lipscomb M. F., Pierce A. K. Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus. Am Rev Respir Dis. 1983 Mar;127(3):335–341. doi: 10.1164/arrd.1983.127.3.335. [DOI] [PubMed] [Google Scholar]
  15. Ooi Y. M., Colten H. R. Genetic defect in secretion of complement C5 in mice. Nature. 1979 Nov 8;282(5735):207–208. doi: 10.1038/282207a0. [DOI] [PubMed] [Google Scholar]
  16. Pierce A. K., Reynolds R. C., Harris G. D. Leukocytic response to inhaled bacteria. Am Rev Respir Dis. 1977 Oct;116(4):679–684. doi: 10.1164/arrd.1977.116.4.679. [DOI] [PubMed] [Google Scholar]
  17. Pivetta O. H., Cassino R. J., Sordelli D. O. Pulmonary cell response to bacterial challenge in mutant mice with some hereditary alterations resembling cystic fibrosis. Life Sci. 1980 Apr 21;26(16):1349–1357. doi: 10.1016/0024-3205(80)90096-x. [DOI] [PubMed] [Google Scholar]
  18. Rehm S. R., Gross G. N., Pierce A. K. Early bacterial clearance from murine lungs. Species-dependent phagocyte response. J Clin Invest. 1980 Aug;66(2):194–199. doi: 10.1172/JCI109844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rosenfeld S. I., Kelly M. E., Leddy J. P. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies. J Clin Invest. 1976 Jun;57(6):1626–1634. doi: 10.1172/JCI108433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Snyderman R., Goetzl E. J. Molecular and cellular mechanisms of leukocyte chemotaxis. Science. 1981 Aug 21;213(4510):830–837. doi: 10.1126/science.6266014. [DOI] [PubMed] [Google Scholar]
  21. Sordelli D. O., Cerquetti M. C., Hooke A. M., Bellanti J. A. Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant. Infect Immun. 1983 Mar;39(3):1275–1279. doi: 10.1128/iai.39.3.1275-1279.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sordelli D. O., Cerquetti M. C., Morris Hooke A., Bellanti J. A. Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract. Infect Immun. 1985 Aug;49(2):265–269. doi: 10.1128/iai.49.2.265-269.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sordelli D. O., Zeligs B. J., Cerquetti M. C., Morris Hooke A., Bellanti J. A. Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis. 1985 Jan;66(1):31–39. [PubMed] [Google Scholar]
  24. Ward P. A., Lepow I. H., Newman L. J. Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol. 1968 Apr;52(4):725–736. [PMC free article] [PubMed] [Google Scholar]
  25. Young L. S., Meyer R. D., Armstrong D. Pseudomonas aeruginosa vaccine in cancer patients. Ann Intern Med. 1973 Oct;79(4):518–527. doi: 10.7326/0003-4819-79-4-518. [DOI] [PubMed] [Google Scholar]
  26. Ziegler E. J., Douglas H. Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia. J Infect Dis. 1979 Mar;139(3):288–296. doi: 10.1093/infdis/139.3.288. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES